Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Marqibo in elderly newly diagnosed ALL
NCT01439347Phase 3Terminated
- Sponsor
- Spectrum Pharmaceuticals, Inc.
- Start
- Mar 2012
- Primary completion
- Nov 2015
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vincristine sulfate liposome injection in acute lymphoblastic leukemia (ALL), sponsored by Spectrum Pharmaceuticals, Inc.. Started Mar 2012; status: terminated.
02
Drugs
vincristine sulfate liposome injection
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT01439347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01439347.